LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway

Oncology Reports

Volumn 25, Issue 6, 2011, Pages 1629-1637

  Li, Fan ^a   Yang, Weimin ^a   Guo, Dongsheng ^a   Hu, Zhiquan ^a   Xu, Hua ^a   Ye, Zhangqun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bladder cancer; Chemotherapy; DNA damage; Epidermal growth factor receptor; LRIG1; Nuclear import

Indexed keywords

ADENOVIRUS VECTOR; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LEUCINE RICH REPEATS AND IMMUNOGLOBULIN LIKE DOMAINS 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; DRUG EXPOSURE; DRUG POTENTIATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 79954567958     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1227     Document Type: Article

References (20)

1. Byun SS, Kim SW, Choi H, Lee C and Lee E: Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities. BJU Int 95: 1086-1090, 2005. (Pubitemid 40655712)
2. Perry JJ and Muss HB: Management of disseminated disease in the patient with bladder cancer. Urol Clin North Am 21: 661-672, 1994. (Pubitemid 24370161)
3. Brozovic A and Osmak M: Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett 251: 1-16, 2007. (Pubitemid 46589761)
4. Lo HW and Hung MC: Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer 94: 184-188, 2006.
5. Dittmann K, Mayer C, Fehrenbacher B, et al: Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 280: 31182-31189, 2005. (Pubitemid 41291855)
6. Dittmann K, Mayer C and Rodemann HP: Inhibition of radiation-induced EGFR nuclear import by C225(Cetuximab) suppresses DNA-PK activity. Radiother Oncol 76: 157-161, 2005. (Pubitemid 41725442)
7. Dittmann K, Mayer C and Rodemann HP: Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function. Strahlenther Onkol 186: 1-6, 2010.
8. Gur G, Rubin C, Katz M, et al: LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J 23: 3270-3281, 2004. (Pubitemid 39209151)
9. Yang WM, Yan ZJ, Ye ZQ and Guo DS: LRIG1, a candidate tumour-suppressor gene in human bladder cancer cell line BIU87. BJU Int 98: 898-902, 2006.
10. Olive PL and Banáth JP: The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1: 23-29, 2006.
11. Końca K, Lankoff A, Banasik A, et al: A cross-platform public domain PC image-analysis program for the comet assay. Mutat Res 534: 15-20, 2003. (Pubitemid 36015835)
12. Benhar M, Engelberg D and Levitzki A: Cisplatin-induced activation of the EGF receptor. Oncogene 21: 8723-8731, 2002.
13. Tice DA, Biscardi JS, Nickles AL and Parsonss SJ: Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci USA 96: 1415-1420, 1999. (Pubitemid 29098465)
14. Dittmann K, Mayer C, Kehlbach R, Rothmund MC and Rodemann HP: Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport. Radiother Oncol 92: 379-382, 2009.
15. Dittmann K, Mayer C, Kehlbach R and Rodemann HP: Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer 7: 69, 2008.
16. Chen DJ and Nirodi CS: The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res 13: 6555-6560, 2007. (Pubitemid 350206788)
17. Kurki P, Vanderlaan M, Dolbeare F, Gray J and Tan EM: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166: 209-219, 1986. (Pubitemid 16030469)
18. El-kott AF, El-baz MA and Mokhtar AA: Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma. Int Urol Nephrol 38: 237-242, 2006. (Pubitemid 44138146)
19. Negishi M, Chiba T, Saraya A, Miyagi S and Iwama A: Dmap1 plays an essential role in the maintenance of genome integrity through the DNA repair process. Genes Cells 14: 1347-1357, 2009.
20. Politi EN, Lazaris AC, Lambropoulou S, Alexopoulou D, Kyriakidou V and Koutselini H: Epidermal growth factor receptor and proliferating cell nuclear antigen expression in urine ThinPrep specimens. Cytopathology 16: 303-308, 2005. (Pubitemid 41784317)